SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-15-007986
Filing Date
2015-06-08
Accepted
2015-06-08 17:20:05
Documents
1
Period of Report
2015-06-05

Document Format Files

Seq Description Document Type Size
1 rrd425572.html 4  
1 rrd425572.xml 4 6223
  Complete submission text file 0001181431-15-007986.txt   7607
Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Blumenkranz Mark S. (Reporting) CIK: 0001614869 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 15919169